https://doi.org/10.4081/mm.2023.11365
Activity of cefiderocol against NDM-producing Enterobacterales from a regional outbreak in the Tuscany region, Italy
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 11 April 2023
Not available.
Downloads
Hackel MA, Tsuji M, Yamano Y, Echols R, Karlowsky JA, Sahm DF. In vitro activity of the siderophore cephalosporin, cefiderocol, against carbapenem-nonsusceptible and multidrug-resistant isolates of Gram-negative bacilli collected
worldwide in 2014 to 2016. Antimicrobial Agents Chemother 2018; 62:e01968-17.
Di Pilato V, Henrici De Angelis L, Aiezza N et al. Resistome and virulome accretion in an NDM-1-producing ST147 sublineage of Klebsiella pneumoniae associated with an outbreak in Tuscany, Italy: a genotypic and phenotypic
characterisation. Lancet Microbe. 2022;3:e224-e234. DOI: https://doi.org/10.1016/S2666-5247(21)00268-8
Coppi M, Antonelli A, Niccolai C et al. Nosocomial outbreak by NDM-1-producing Klebsiella pneumoniae highly resistant to cefiderocol, Florence, Italy, August 2021 to June 2022. Euro Surveill. 2022;27:2200795. DOI: https://doi.org/10.2807/1560-7917.ES.2022.27.43.2200795
Hackel MA, Tsuji M, Yamano Y et al. Reproducibility of broth microdilution MICs for the novel siderophore cephalosporin, cefiderocol, determined using iron-depleted cation-adjusted Mueller-Hinton broth. Diagn Microbiol Infect Dis.
;94:321-325.
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.